Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells (Q39839523)

15 September 2017

Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells (English)

1 reference

15 September 2017

0 references

0 references

Shigeo Ohba

1

1 reference

15 September 2017

Yuichi Hirose

series ordinal

2

1 reference

15 September 2017

Takeshi Kawase

series ordinal

3

1 reference

15 September 2017

Hirotoshi Sano

series ordinal

4

1 reference

15 September 2017

11 June 2009

1 reference

Journal of Neuro-Oncology

15 September 2017

1 reference

15 September 2017

95

1 reference

15 September 2017

3

1 reference

15 September 2017

307-316

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-009-9929-x

15 September 2017

0 references

cites work

Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Role of JNK activation in apoptosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

c-Jun knockdown sensitizes osteosarcoma to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

JNK1 and JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Suppression of p53-dependent senescence by the JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

JNK pathway: diseases and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9929-X

Chemical genetic analysis of the time course of signal transduction by JNK

21 January 2018

1 reference

12 December 2020

Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors

1 reference

12 December 2020

Selective interaction of JNK protein kinase isoforms with transcription factors

1 reference

12 December 2020

p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells

1 reference

12 December 2020

Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells

1 reference

12 December 2020

The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation

1 reference

12 December 2020

Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment

1 reference

12 December 2020

10.1007/S11060-009-9929-X

Identifiers

DOI

1 reference

15 September 2017

1 reference